Market Closed

PPCB
Propanc Biopharma
$ 1.94
1.04%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Propanc Biopharma News

Latest Propanc Biopharma Stock News & PPCB Headlines

Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer
14 days ago | globenewswire.com
Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients
17 days ago | globenewswire.com
Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients
19 days ago | globenewswire.com
Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability
21 days ago | globenewswire.com
Propanc Biopharma's Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells
a month ago | globenewswire.com
Propanc Biopharma Announces Publication of Pilot Study Demonstrating Potent Anti-Tumor Efficacy of PRP Pancreatic Proenzyme Formulation in Pancreatic & Ovarian Cancer
a month ago | globenewswire.com
Propanc Biopharma Inc (NASDAQ:PPCB) Sees Significant Increase in Short Interest
a month ago | defenseworld.net
Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines' Daraxonrasib
a month ago | globenewswire.com
Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results
2 months ago | globenewswire.com
Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

PPCB
Propanc Biopharma
$ 1.94
1.04%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago